Safety and efficacy of mycophenolate in COVID-19: a nonrandomised prospective study in western IndiaResearch in context

Safety and efficacy of mycophenolate in COVID-19: a nonrandomised prospective study in western IndiaResearch in context

Summary: Background: Antivirals and immunosuppressive agents are used with variable success in the treatment of COVID-19. Mycophenolate, an inhibitor of enzyme inosine monophosphate dehydrogenase, is an immunosuppressant used to prevent allograft rejection and other autoimmune diseases. Few laborat...

Full description

Bibliographic Details
Main Authors: Atul Sajgure, Ajit Kulkarni, Atul Joshi, Vasanti Sajgure, Vaishali Pathak, Rashida Melinkeri, Shilpa Pathak, Sumit Agrawal, Manoj Naik, Milind Rajurkar, Ameya Sajgure, Girish Date
Format: Article
Language:English
Published: Elsevier 2023-04-01
Series:The Lancet Regional Health - Southeast Asia
Subjects:
COVID-19
Mycophenolate
Cytokine storm
Mortality
Immunosuppressive agents
Online Access:http://www.sciencedirect.com/science/article/pii/S2772368223000148

Internet

http://www.sciencedirect.com/science/article/pii/S2772368223000148

Similar Items